Skip to Content

Irbesartan BMS

Active Substance: irbesartan
Common Name: irbesartan
ATC Code: C09CA04
Marketing Authorisation Holder: Bristol-Myers Squibb Pharma EEIG
Active Substance: irbesartan
Status: Withdrawn
Authorisation Date: 2007-01-19
Therapeutic Area: Hypertension
Pharmacotherapeutic Group: Agents acting on the renin-angiotensin system

Therapeutic Indication

Treatment of essential hypertension.
Treatment of renal disease in patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen (see section 5.1).

The marketing authorisation for Irbesartan BMS has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide